Document ID: chunk:federal_register_of_legislation:F2025C00158:clause:4_1:p12
Version: federal_register_of_legislation:F2025C00158
Segment Type: clause
Provision Reference: sch 4 cl 1 (pt 12/191)
Character Range: 9572214–9583283

frequent episodes of asthma while receiving treatment with oral corticosteroids or optimal doses of inhaled corticosteroids;
                                                                                                                                                                                                                               Patient must be aged 12 years or over.
C4409               P4409          CN4409           Apixaban                                                                                                                                                                   Prevention of venous thromboembolism                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Compliance with Authority Required procedures - Streamlined Authority Code 4409
                                                                                                                                                                                                                               Patient must be undergoing total hip replacement; AND
                                                                                                                                                                                                                               Patient must require up to 15 days supply to complete a course of treatment.
C4414               P4414          CN4414           Amino acid formula supplemented with prebiotics, probiotics and long chain polyunsaturated fatty acids                                                                     Eosinophilic oesophagitis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Compliance with Authority Required procedures
                                                                                                                                                                                                                               Continuing treatment
                                                    Amino acid synthetic formula supplemented with long chain polyunsaturated fatty acids and medium chain triglycerides                                                       Must be treated by a clinical immunologist, suitably qualified allergist or gastroenterologist; AND
                                                                                                                                                                                                                               Patient must have responded to an initial course of PBS-subsidised treatment;
                                                    Amino acids-synthetic, formula                                                                                                                                             Patient must be 18 years of age or less.
                                                                                                                                                                                                                               Response to initial treatment is demonstrated by oesophageal biopsy specimens obtained by endoscopy, where the most densely involved oesophageal biopsy had 5 or less eosinophils in any single 400 x high powered field, along with normal antral and duodenal biopsies. The response criteria will not be deemed to have been met if oral steroids were commenced during initial treatment.
C4415               P4415          CN4415           Amino acid formula supplemented with prebiotics, probiotics and long chain polyunsaturated fatty acids                                                                     Severe intestinal malabsorption including short bowel syndrome                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Compliance with Authority Required procedures
                                                                                                                                                                                                                               Patient must have failed to respond to protein hydrolysate formulae.  or
                                                    Amino acid formula with fat, carbohydrate, vitamins, minerals, trace elements and medium chain triglycerides                                                               Patient must have been receiving parenteral nutrition.

                                                    Amino acid synthetic formula supplemented with long chain polyunsaturated fatty acids

                                                    Amino acid synthetic formula supplemented with long chain polyunsaturated fatty acids and medium chain triglycerides

                                                    Amino acids-synthetic, formula

C4418               P4418          CN4418           Perindopril with amlodipine                                                                                                                                                Stable coronary heart disease
                                                                                                                                                                                                                               The treatment must not be for the initiation of therapy for coronary heart disease; AND
                                                                                                                                                                                                                               The condition must be stabilised by treatment with perindopril and amlodipine at the same doses.
C4433               P4433          CN4433           Pamidronic acid                                                                                                                                                            Hypercalcaemia of malignancy                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Compliance with Authority Required procedures - Streamlined Authority Code 4433
                                                                                                                                                                                                                               Patient must have a malignancy refractory to anti-neoplastic therapy.
C4438               P4438          CN4438           Carbohydrate, fat, vitamins, minerals and trace elements                                                                                                                   Proven inborn errors of protein metabolism
                                                                                                                                                                                                                               Patient must be unable to meet their energy requirements with permitted food and formulae.
                                                    Carbohydrate, fat, vitamins, minerals and trace elements and supplemented with arachidonic acid and docosahexaenoic acid

                                                    Triglycerides, long chain with glucose polymer

                                                    Triglycerides, medium chain and long chain with glucose polymer

C4454               P4454          CN4454           Abacavir                                                                                                                                                                   HIV infection                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Compliance with Authority Required procedures - Streamlined Authority Code 4454
                                                                                                                                                                                                                               Continuing
                                                    Atazanavir                                                                                                                                                                 Patient must have previously received PBS-subsidised therapy for HIV infection; AND
                                                                                                                                                                                                                               The treatment must be in combination